Comparing the therapeutic effects of lacto-Ovo-vegetarian and standard diet on the lipid profile, liver enzymes, and sonographic results of obese and overweight patients with nonalcoholic fatty liver disease: A randomized controlled trial.

Vice Chancellor for Research, Isfahan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新: 2020年8月17日

试验速览

暂无简介。

•Over-weight or obese patients with the nonalcoholic fatty liver disease confirmed with imaging techniques
•increased levels of liver enzymes (serum levels of alanine aminotransferase and aspartate aminotransferase more than 40 U/L);
•Body Mass Index (BMI) of them is greater than 24.9 and lower than 40

•Alcohol consumption
•Pregnant and lactating women
•Any known forms of hepatic or metabolic disease except NAFLD, such as hereditary hemochromatosis, Wilson’s disease, cirosis,
•other metabolic disease
•history of gastric bypass or intestine surgery
•Taking hepatotoxic drugs such as calcium channel blocker, methotrexate, amiodarone, chloroquine and anti inflammatory drugs;
•Using nutrition supplements or vegetarian diets
•Hormone Therapy
•Patients with a history of hypothyroidism,
•Cushing’s syndrome
•renal failure
•kidney stones.
•Participants with less than 80% of adherence to the dietary plan are going to be excluded.

发起方

Vice Chancellor for Research, Isfahan University of Medical Sciences